PHOSIMER (Osimertinib) 80mg*30 | Pharma 2 Laos Generic | GLT

REQUEST A QUOTE

Tap "Request a Quote" to open WhatsApp — the product details are already filled in. Just add your quantity and destination country.

  • We reply within 24 hours with pricing, availability & COA
  • Serves individuals and institutions worldwide

Prefer email? [email protected] · +86 15234153837

Share
Product description

Generic Information: PHOSIMER (Osimertinib) 80mg — Laos

PHOSIMER is the osimertinib generic produced by Pharma 2 Vientiane, also known as National Pharmaceutical Factory No. 2 of Laos — a long-established state-linked manufacturer under the Lao Ministry of Health. The product is supplied as 80 mg film-coated tablets in 30-tablet packs. Pharma 2 Vientiane is one of the most comprehensive drug producers in Laos, with a broad portfolio spanning oral solids, injectables and infusions, and it manufactures PHOSIMER under Lao GMP standards.

Because Pharma 2 Vientiane is a well-known domestic institution, PHOSIMER carries a level of local traceability that some buyers value. As with all generics, the active ingredient — osimertinib — and the 80 mg dose are the key verification points.

What Is PHOSIMER Used For?

PHOSIMER treats EGFR mutation-positive non-small cell lung cancer. It is used first-line for advanced EGFR-mutant disease, as adjuvant therapy after surgery in eligible early-stage patients, and for T790M-positive disease after progression on a prior EGFR TKI. Its penetration into the central nervous system makes it useful when brain metastases are present.

How Does PHOSIMER Work?

The osimertinib in PHOSIMER irreversibly inhibits mutated EGFR, targeting exon 19 deletions, L858R mutations and the T790M resistance mutation while sparing wild-type EGFR. This mutant-selective blockade is the basis of its effectiveness across treatment lines and its relatively tolerable side-effect profile.

Indications

  • First-line advanced EGFR-mutant NSCLC.
  • Adjuvant therapy after resection of EGFR-mutant NSCLC.
  • T790M-positive NSCLC after prior EGFR-TKI therapy.

Dosage and Administration

PHOSIMER is taken as one 80 mg tablet once daily, with or without food, swallowed whole. Missed doses beyond 12 hours are skipped. The dose can be reduced to 40 mg daily for side-effect management, and treatment continues until progression or unacceptable toxicity.

Side Effects

Common adverse events include diarrhoea, rash, dry skin, nail changes, stomatitis and fatigue. Rare but serious risks such as interstitial lung disease, QT prolongation and cardiomyopathy warrant monitoring; new respiratory symptoms or palpitations should be reported immediately.

Storage

Store PHOSIMER below 30°C, in a dry place, in the original container and away from children. Use before the expiry date.

Why Choose the GLT?

GLT verifies PHOSIMER batches against Pharma 2 Vientiane's documentation and provides a transparent Lao supply route. Lao generics of osimertinib are typically several times cheaper than branded Tagrisso in Western markets, making long-term EGFR-targeted therapy far more sustainable. We support both patient and institutional orders with clear documentation and direct support.

How to Order PHOSIMER from GLT

To order PHOSIMER 80 mg (30 tablets), message GLT on WhatsApp at +86 15234153837 or email [email protected]. Provide your quantity, destination country and order type, and we will confirm availability, batch details and shipping terms.

FAQ

Who makes PHOSIMER? PHOSIMER is manufactured by Pharma 2 Vientiane (National Pharmaceutical Factory No. 2 of Laos).

Is PHOSIMER the same as Tagrisso? PHOSIMER contains the same active ingredient (osimertinib) at the same 80 mg dose as Tagrisso.

Can I buy PHOSIMER online? Yes, GLT supplies PHOSIMER internationally; contact us on WhatsApp or email.

Related Oncology Products

SPINRAZA (Nusinersen) 12mg/5mL | Buy from China | SMA Therapy | GLT

Biogen's first-in-class antisense oligonucleotide for SMA, NMPA-approved and nationally reimbursed in China — buy from...

Baricent (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Incepta Pharmaceuticals Ltd. | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Incepta Pharmaceuticals Ltd. (Bangladesh) — an affordable alternative to Olumiant...

KeZeRui 科瑞泽 (Avatrombopag) 20mg*10 Tablets | Sichuan Kelun China | GLT

KeZeRui — national-procurement avatrombopag from Sichuan Kelun Pharmaceutical, China's integrated API + tablet maker

XinKePing 欣可平 (Avatrombopag) 20mg*10 Tablets | Nanjing Hencer China | GLT

XinKePing — API-plus-tablet integrated avatrombopag from Nanjing Hencer Pharmaceutical (Jemcare group), China Mainland

Mounjaro KwikPen (Tirzepatide) 10–60mg/2.4mL Multi-Dose | Eli Lilly USA | GLT

Mounjaro KwikPen — Eli Lilly single-patient multi-dose pen, six US strengths (10–60mg/2.4mL, 4 doses each)...

LuciAvat (Avatrombopag) 20mg*28 Tablets | Lucius Pharmaceuticals Laos | GLT

LuciAvat — avatrombopag 20mg (23.6mg maleate) film-coated tablets by Lucius Pharmaceuticals (Lao) Co., Ltd., Vientiane

Olumiant (Baricitinib) 2mg/4mg Tablets | JAK1/JAK2 Inhibitor | Eli Lilly USA | GLT

Eli Lilly's selective JAK1/JAK2 inhibitor for rheumatoid arthritis, atopic dermatitis and severe alopecia areata.

Orforglipron (OriYo) 0.8–17.2mg Tablets | Bangladesh Generic Oral GLP-1 | GLT

National Drug Co. generic orforglipron, 6-dose titration for weight management